Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease

被引：0
|
作者：
Barone, P.
Poewe, W.
Tolosa, E.
Rascol, O.
Massey, D.
Debieuvre, C.
Albrecht, S.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [31] A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease
    Damier, Philippe
    Degos, Bertrand
    Castelonovo, Giovanni
    Anheim, Mathieu
    Benatru, Isabelle
    Carriere, Nicolas
    Colin, Olivier
    Defebvre, Luc
    Deverdal, Marie
    Eusebio, Alexandre
    Ferrier, Vanessa
    Giordana, Caroline
    Houeto, Jean-Luc
    Le Dily, Severine
    Mongin, Marie
    Thiriez, Claire
    Tranchant, Christine
    Ravel, Denis
    Corvol, Jean-Christophe
    Rascol, Olivier
    Ben Ari, Yehezkel
    MOVEMENT DISORDERS, 2024, 39 (03) : 618 - 622
  • [32] A double-blind, placebo-controlled trial of donepezil in patients with Parkinson's Disease and related dementia
    Brashear, A
    Kuhn, ER
    Lane, KA
    Farlow, MR
    Unverzagt, FW
    NEUROLOGY, 2004, 62 (07) : A524 - A525
  • [33] A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease
    Ondo, WG
    Hunter, C
    Moore, W
    NEUROLOGY, 2004, 62 (01) : 37 - 40
  • [34] A randomized, double-blind, placebo-controlled study of atornoxetine for freezing of gait in Parkinson's disease
    Nashatizadeh, M. M.
    Jimenez, J. E.
    Davidson, A. L.
    Jankovic, J.
    MOVEMENT DISORDERS, 2008, 23 (01) : S219 - S219
  • [35] Amantadine against dyskinesias in Parkinson's disease: a cross-over, double-blind, randomized placebo-controlled trial
    Sawada, H.
    Oeda, T.
    Kuno, S.
    Nomoto, M.
    Yamamoto, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 553 - 553
  • [36] Clozapine improves dyskinesias in Parkinson disease - A double-blind, placebo-controlled study
    Durif, F
    Debilly, B
    Galitzky, M
    Morand, D
    Viallet, F
    Borg, M
    Thobois, S
    Broussolle, E
    Rascol, O
    NEUROLOGY, 2004, 62 (03) : 381 - 388
  • [37] Double-blind, placebo-controlled trial of pramipexole in Progressive Supranuclear Palsy (PSP)
    Guttman, M
    NEUROLOGY, 2001, 56 (08) : A458 - A459
  • [38] Effects of pramipexole on the motor response to levodopa infusion in Parkinson's disease: A double-blind, placebo controlled crossover study
    Brodsky, M. A.
    Barnard, M. C.
    Park, B. S.
    Nutt, J. G.
    MOVEMENT DISORDERS, 2007, 22 : S151 - S152
  • [39] Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Athauda, Dilan
    Maclagan, Kate
    Skene, Simon S.
    Bajwa-Joseph, Martha
    Letchford, Dawn
    Chowdhury, Kashfia
    Hibbert, Steve
    Budnik, Natalia
    Zampedri, Luca
    Dickson, John
    Li, Yazhou
    Aviles-Olmos, Iciar
    Warner, Thomas T.
    Limousin, Patricia
    Lees, Andrew J.
    Greig, Nigel H.
    Tebbs, Susan
    Foltynie, Thomas
    LANCET, 2017, 390 (10103): : 1664 - 1675
  • [40] Liraglutide once daily versus placebo in Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Wu, T.
    Bresee, C.
    Wertheimer, J.
    Hogg, E.
    Malatt, C.
    Tan, E.
    Pomeroy, H.
    Obialisi, G.
    Tagliati, M.
    MOVEMENT DISORDERS, 2022, 37 : S359 - S360
12345